APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Chinese Medicine Injection for Bones and Muscles

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chinese Medicine Injection for Bones and Muscles Market Outlook and Growth Opportunities 2026

Report ID 173977340423 December 2025192 pages

Choose your research edition.

Industry ResearchChinese Medicine Injection for Bones and Muscles Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Chinese Medicine Injection for Bones and Muscles Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Chinese Medicine Injection for Bones and Muscles Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chinese Medicine Injection for Bones and Muscles Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Chinese Medicine Injection for Bones and Muscles Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Chinese Medicine Injection for Bones and Muscles market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chinese Medicine Injection for Bones and Muscles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chinese Medicine Injection for Bones and Muscles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chinese Medicine Injection for Bones and Muscles is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chinese Medicine Injection for Bones and Muscles market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chinese Medicine Injection for Bones and Muscles market include Zhejiang Taikang Pharmaceutical, Xinjiang Yinduolan Pharmaceutical, Lonch Group, Hunan Zhengqing Pharmaceutical, Sinopharm Group Xinjiang Pharmaceutical, Guangdong Xinfeng Pharmaceutical and Anhui Fengyang Keyuan Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chinese Medicine Injection for Bones and Muscles market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chinese Medicine Injection for Bones and Muscles and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chinese Medicine Injection for Bones and Muscles sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chinese Medicine Injection for Bones and Muscles market size, projected growth trends, production technologies, key applications, and end-use industries.

Chinese Medicine Injection for Bones and Muscles Segment by Company

Zhejiang Taikang Pharmaceutical

Xinjiang Yinduolan Pharmaceutical

Lonch Group

Hunan Zhengqing Pharmaceutical

Sinopharm Group Xinjiang Pharmaceutical

Guangdong Xinfeng Pharmaceutical

Anhui Fengyang Keyuan Pharmaceutical

Chinese Medicine Injection for Bones and Muscles Segment by Type

Xuelian Injection

Wild Papaya Injection

Zhengqing Fengtongning Injection

Zushima Injection

Other

Chinese Medicine Injection for Bones and Muscles Segment by Application

Secondary Hospital

Tertiary Hospital

Other

Chinese Medicine Injection for Bones and Muscles Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Chinese Medicine Injection for Bones and Muscles status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Chinese Medicine Injection for Bones and Muscles market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chinese Medicine Injection for Bones and Muscles significant trends, drivers, influence factors in global and regions.

6. To analyze Chinese Medicine Injection for Bones and Muscles competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Medicine Injection for Bones and Muscles market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Medicine Injection for Bones and Muscles and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Medicine Injection for Bones and Muscles.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chinese Medicine Injection for Bones and Muscles market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chinese Medicine Injection for Bones and Muscles industry.

Chapter 3: Detailed analysis of Chinese Medicine Injection for Bones and Muscles manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Chinese Medicine Injection for Bones and Muscles in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Chinese Medicine Injection for Bones and Muscles in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chinese Medicine Injection for Bones and Muscles Industry Trends Table 2. Chinese Medicine Injection for Bones and Muscles Industry Drivers Table 3. Chinese Medicine Injection for Bones and Muscles Industry Opportunities and Challenges Table 4. Chinese Medicine Injection for Bones and Muscles Industry Restraints Table 5. Global Chinese Medicine Injection for Bones and Muscles Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chinese Medicine Injection for Bones and Muscles Revenue Share by Company (2021-2026) Table 7. Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Company (k units) & (2021-2026) Table 8. Global Chinese Medicine Injection for Bones and Muscles Sales Volume Share by Company (2021-2026) Table 9. Global Chinese Medicine Injection for Bones and Muscles Average Price (USD/unit) of Company (2021-2026) Table 10. Global Chinese Medicine Injection for Bones and Muscles Company Ranking, (2024-2026) & (USD Million) Table 11. Global Chinese Medicine Injection for Bones and Muscles Key Company Manufacturing Base & Headquarters Table 12. Global Chinese Medicine Injection for Bones and Muscles Company, Product Type & Application Table 13. Global Chinese Medicine Injection for Bones and Muscles Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Chinese Medicine Injection for Bones and Muscles by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Xuelian Injection Table 18. Significant Companies of Wild Papaya Injection Table 19. Significant Companies of Zhengqing Fengtongning Injection Table 20. Significant Companies of Zushima Injection Table 21. Significant Companies of Other Table 22. Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Type (2021-2026) & (k units) Table 24. Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Type (2027-2032) & (k units) Table 25. Global Chinese Medicine Injection for Bones and Muscles Sales Volume Share by Type (2021-2026) Table 26. Global Chinese Medicine Injection for Bones and Muscles Sales Volume Share by Type (2027-2032) Table 27. Global Chinese Medicine Injection for Bones and Muscles Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Chinese Medicine Injection for Bones and Muscles Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Chinese Medicine Injection for Bones and Muscles Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type (2021-2026) Table 31. Global Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Secondary Hospital Table 33. Significant Companies of Tertiary Hospital Table 34. Significant Companies of Other Table 35. Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 36. Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Application (2021-2026) & (k units) Table 37. Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Application (2027-2032) & (k units) Table 38. Global Chinese Medicine Injection for Bones and Muscles Sales Volume Share by Application (2021-2026) Table 39. Global Chinese Medicine Injection for Bones and Muscles Sales Volume Share by Application (2027-2032) Table 40. Global Chinese Medicine Injection for Bones and Muscles Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Chinese Medicine Injection for Bones and Muscles Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Chinese Medicine Injection for Bones and Muscles Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application (2021-2026) Table 44. Global Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application (2027-2032) Table 45. Global Chinese Medicine Injection for Bones and Muscles Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 46. Global Chinese Medicine Injection for Bones and Muscles Sales by Region (2021-2026) & (k units) Table 47. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Region (2021-2026) Table 48. Global Chinese Medicine Injection for Bones and Muscles Sales by Region (2027-2032) & (k units) Table 49. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Region (2027-2032) Table 50. Global Chinese Medicine Injection for Bones and Muscles Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Chinese Medicine Injection for Bones and Muscles Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Chinese Medicine Injection for Bones and Muscles Sales Value Share by Region (2021-2026) Table 53. Global Chinese Medicine Injection for Bones and Muscles Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Chinese Medicine Injection for Bones and Muscles Sales Value Share by Region (2027-2032) Table 55. Global Chinese Medicine Injection for Bones and Muscles Market Average Price (USD/unit) by Region (2021-2026) Table 56. Global Chinese Medicine Injection for Bones and Muscles Market Average Price (USD/unit) by Region (2027-2032) Table 57. Global Chinese Medicine Injection for Bones and Muscles Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 58. Global Chinese Medicine Injection for Bones and Muscles Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Chinese Medicine Injection for Bones and Muscles Sales by Country (2021-2026) & (k units) Table 60. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Country (2021-2026) Table 61. Global Chinese Medicine Injection for Bones and Muscles Sales by Country (2027-2032) & (k units) Table 62. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Country (2027-2032) Table 63. Global Chinese Medicine Injection for Bones and Muscles Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Chinese Medicine Injection for Bones and Muscles Sales Value Market Share by Country (2021-2026) Table 65. Global Chinese Medicine Injection for Bones and Muscles Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Chinese Medicine Injection for Bones and Muscles Sales Value Market Share by Country (2027-2032) Table 67. Zhejiang Taikang Pharmaceutical Company Information Table 68. Zhejiang Taikang Pharmaceutical Business Overview Table 69. Zhejiang Taikang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 70. Zhejiang Taikang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 71. Zhejiang Taikang Pharmaceutical Recent Development Table 72. Xinjiang Yinduolan Pharmaceutical Company Information Table 73. Xinjiang Yinduolan Pharmaceutical Business Overview Table 74. Xinjiang Yinduolan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 75. Xinjiang Yinduolan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 76. Xinjiang Yinduolan Pharmaceutical Recent Development Table 77. Lonch Group Company Information Table 78. Lonch Group Business Overview Table 79. Lonch Group Chinese Medicine Injection for Bones and Muscles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 80. Lonch Group Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 81. Lonch Group Recent Development Table 82. Hunan Zhengqing Pharmaceutical Company Information Table 83. Hunan Zhengqing Pharmaceutical Business Overview Table 84. Hunan Zhengqing Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 85. Hunan Zhengqing Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 86. Hunan Zhengqing Pharmaceutical Recent Development Table 87. Sinopharm Group Xinjiang Pharmaceutical Company Information Table 88. Sinopharm Group Xinjiang Pharmaceutical Business Overview Table 89. Sinopharm Group Xinjiang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Sinopharm Group Xinjiang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 91. Sinopharm Group Xinjiang Pharmaceutical Recent Development Table 92. Guangdong Xinfeng Pharmaceutical Company Information Table 93. Guangdong Xinfeng Pharmaceutical Business Overview Table 94. Guangdong Xinfeng Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Guangdong Xinfeng Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 96. Guangdong Xinfeng Pharmaceutical Recent Development Table 97. Anhui Fengyang Keyuan Pharmaceutical Company Information Table 98. Anhui Fengyang Keyuan Pharmaceutical Business Overview Table 99. Anhui Fengyang Keyuan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. Anhui Fengyang Keyuan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio Table 101. Anhui Fengyang Keyuan Pharmaceutical Recent Development Table 102. Key Raw Materials Table 103. Raw Materials Key Suppliers Table 104. Chinese Medicine Injection for Bones and Muscles Distributors List Table 105. Chinese Medicine Injection for Bones and Muscles Customers List Table 106. Research Programs/Design for This Report Table 107. Authors List of This Report Table 108. Secondary Sources Table 109. Primary Sources List of Figures Figure 1. Chinese Medicine Injection for Bones and Muscles Product Image Figure 2. Global Chinese Medicine Injection for Bones and Muscles Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chinese Medicine Injection for Bones and Muscles Sales Value (2021-2032) & (US$ Million) Figure 4. Global Chinese Medicine Injection for Bones and Muscles Sales (2021-2032) & (k units) Figure 5. Global Chinese Medicine Injection for Bones and Muscles Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Chinese Medicine Injection for Bones and Muscles Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Xuelian Injection Image Figure 10. Wild Papaya Injection Image Figure 11. Zhengqing Fengtongning Injection Image Figure 12. Zushima Injection Image Figure 13. Other Image Figure 14. Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Chinese Medicine Injection for Bones and Muscles Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Chinese Medicine Injection for Bones and Muscles Sales Volume Share by Type (2021-2032) Figure 17. Global Chinese Medicine Injection for Bones and Muscles Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Chinese Medicine Injection for Bones and Muscles Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type (2021-2032) Figure 20. Secondary Hospital Image Figure 21. Tertiary Hospital Image Figure 22. Other Image Figure 23. Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 24. Global Chinese Medicine Injection for Bones and Muscles Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Chinese Medicine Injection for Bones and Muscles Sales Volume Share by Application (2021-2032) Figure 26. Global Chinese Medicine Injection for Bones and Muscles Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Chinese Medicine Injection for Bones and Muscles Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application (2021-2032) Figure 29. Global Chinese Medicine Injection for Bones and Muscles Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 30. Global Chinese Medicine Injection for Bones and Muscles Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Chinese Medicine Injection for Bones and Muscles Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Chinese Medicine Injection for Bones and Muscles Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Chinese Medicine Injection for Bones and Muscles Sales Value (2021-2032) & (US$ Million) Figure 34. North America Chinese Medicine Injection for Bones and Muscles Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Chinese Medicine Injection for Bones and Muscles Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Chinese Medicine Injection for Bones and Muscles Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Chinese Medicine Injection for Bones and Muscles Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Chinese Medicine Injection for Bones and Muscles Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Chinese Medicine Injection for Bones and Muscles Sales Value (2021-2032) & (US$ Million) Figure 40. South America Chinese Medicine Injection for Bones and Muscles Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Chinese Medicine Injection for Bones and Muscles Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Chinese Medicine Injection for Bones and Muscles Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Chinese Medicine Injection for Bones and Muscles Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Chinese Medicine Injection for Bones and Muscles Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • Xuelian Injection
  • Wild Papaya Injection
  • Zhengqing Fengtongning Injection
  • Zushima Injection
  • Other
Applications
  • Secondary Hospital
  • Tertiary Hospital
  • Other
Companies covered
  • Zhejiang Taikang Pharmaceutical
  • Xinjiang Yinduolan Pharmaceutical
  • Lonch Group
  • Hunan Zhengqing Pharmaceutical
  • Sinopharm Group Xinjiang Pharmaceutical
  • Guangdong Xinfeng Pharmaceutical
  • Anhui Fengyang Keyuan Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chinese Medicine Injection for Bones and Muscles Sales Value (2021-2032)
  4. 1.2.2 Global Chinese Medicine Injection for Bones and Muscles Sales Volume (2021-2032)
  5. 1.2.3 Global Chinese Medicine Injection for Bones and Muscles Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Chinese Medicine Injection for Bones and Muscles Market Dynamics
  1. 2.1 Chinese Medicine Injection for Bones and Muscles Industry Trends
  2. 2.2 Chinese Medicine Injection for Bones and Muscles Industry Drivers
  3. 2.3 Chinese Medicine Injection for Bones and Muscles Industry Opportunities and Challenges
  4. 2.4 Chinese Medicine Injection for Bones and Muscles Industry Restraints
3 Chinese Medicine Injection for Bones and Muscles Market by Company
  1. 3.1 Global Chinese Medicine Injection for Bones and Muscles Company Revenue Ranking in 2025
  2. 3.2 Global Chinese Medicine Injection for Bones and Muscles Revenue by Company (2021-2026)
  3. 3.3 Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Company (2021-2026)
  4. 3.4 Global Chinese Medicine Injection for Bones and Muscles Average Price by Company (2021-2026)
  5. 3.5 Global Chinese Medicine Injection for Bones and Muscles Company Ranking (2024-2026)
  6. 3.6 Global Chinese Medicine Injection for Bones and Muscles Company Manufacturing Base and Headquarters
  7. 3.7 Global Chinese Medicine Injection for Bones and Muscles Company Product Type and Application
  8. 3.8 Global Chinese Medicine Injection for Bones and Muscles Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Chinese Medicine Injection for Bones and Muscles Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Chinese Medicine Injection for Bones and Muscles Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Chinese Medicine Injection for Bones and Muscles Market by Type
  1. 4.1 Chinese Medicine Injection for Bones and Muscles Type Introduction
  2. 4.1.1 Xuelian Injection
  3. 4.1.2 Wild Papaya Injection
  4. 4.1.3 Zhengqing Fengtongning Injection
  5. 4.1.4 Zushima Injection
  6. 4.1.5 Other
  7. 4.2 Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Type
  8. 4.2.1 Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Chinese Medicine Injection for Bones and Muscles Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Type
  12. 4.3.1 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Type (2021-2032)
  14. 4.3.3 Global Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type (2021-2032)
5 Chinese Medicine Injection for Bones and Muscles Market by Application
  1. 5.1 Chinese Medicine Injection for Bones and Muscles Application Introduction
  2. 5.1.1 Secondary Hospital
  3. 5.1.2 Tertiary Hospital
  4. 5.1.3 Other
  5. 5.2 Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Application
  6. 5.2.1 Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chinese Medicine Injection for Bones and Muscles Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Chinese Medicine Injection for Bones and Muscles Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Application
  10. 5.3.1 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Application (2021-2032)
  12. 5.3.3 Global Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application (2021-2032)
6 Chinese Medicine Injection for Bones and Muscles Regional Sales and Value Analysis
  1. 6.1 Global Chinese Medicine Injection for Bones and Muscles Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chinese Medicine Injection for Bones and Muscles Sales by Region (2021-2032)
  3. 6.2.1 Global Chinese Medicine Injection for Bones and Muscles Sales by Region: 2021-2026
  4. 6.2.2 Global Chinese Medicine Injection for Bones and Muscles Sales by Region (2027-2032)
  5. 6.3 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Region (2021-2032)
  7. 6.4.1 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Region: 2021-2026
  8. 6.4.2 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Region (2027-2032)
  9. 6.5 Global Chinese Medicine Injection for Bones and Muscles Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Chinese Medicine Injection for Bones and Muscles Sales Value (2021-2032)
  12. 6.6.2 North America Chinese Medicine Injection for Bones and Muscles Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Chinese Medicine Injection for Bones and Muscles Sales Value (2021-2032)
  15. 6.7.2 Europe Chinese Medicine Injection for Bones and Muscles Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Chinese Medicine Injection for Bones and Muscles Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Chinese Medicine Injection for Bones and Muscles Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Chinese Medicine Injection for Bones and Muscles Sales Value (2021-2032)
  21. 6.9.2 South America Chinese Medicine Injection for Bones and Muscles Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Chinese Medicine Injection for Bones and Muscles Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Chinese Medicine Injection for Bones and Muscles Sales Value Share by Country, 2025 VS 2032
7 Chinese Medicine Injection for Bones and Muscles Country-level Sales and Value Analysis
  1. 7.1 Global Chinese Medicine Injection for Bones and Muscles Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Chinese Medicine Injection for Bones and Muscles Sales by Country (2021-2032)
  4. 7.3.1 Global Chinese Medicine Injection for Bones and Muscles Sales by Country (2021-2026)
  5. 7.3.2 Global Chinese Medicine Injection for Bones and Muscles Sales by Country (2027-2032)
  6. 7.4 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Country (2021-2032)
  7. 7.4.1 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Country (2021-2026)
  8. 7.4.2 Global Chinese Medicine Injection for Bones and Muscles Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Chinese Medicine Injection for Bones and Muscles Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Chinese Medicine Injection for Bones and Muscles Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Chinese Medicine Injection for Bones and Muscles Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Taikang Pharmaceutical
  2. 8.1.1 Zhejiang Taikang Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Taikang Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Taikang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Taikang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio
  6. 8.1.5 Zhejiang Taikang Pharmaceutical Recent Developments
  7. 8.2 Xinjiang Yinduolan Pharmaceutical
  8. 8.2.1 Xinjiang Yinduolan Pharmaceutical Company Information
  9. 8.2.2 Xinjiang Yinduolan Pharmaceutical Business Overview
  10. 8.2.3 Xinjiang Yinduolan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Xinjiang Yinduolan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio
  12. 8.2.5 Xinjiang Yinduolan Pharmaceutical Recent Developments
  13. 8.3 Lonch Group
  14. 8.3.1 Lonch Group Company Information
  15. 8.3.2 Lonch Group Business Overview
  16. 8.3.3 Lonch Group Chinese Medicine Injection for Bones and Muscles Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Lonch Group Chinese Medicine Injection for Bones and Muscles Product Portfolio
  18. 8.3.5 Lonch Group Recent Developments
  19. 8.4 Hunan Zhengqing Pharmaceutical
  20. 8.4.1 Hunan Zhengqing Pharmaceutical Company Information
  21. 8.4.2 Hunan Zhengqing Pharmaceutical Business Overview
  22. 8.4.3 Hunan Zhengqing Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Hunan Zhengqing Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio
  24. 8.4.5 Hunan Zhengqing Pharmaceutical Recent Developments
  25. 8.5 Sinopharm Group Xinjiang Pharmaceutical
  26. 8.5.1 Sinopharm Group Xinjiang Pharmaceutical Company Information
  27. 8.5.2 Sinopharm Group Xinjiang Pharmaceutical Business Overview
  28. 8.5.3 Sinopharm Group Xinjiang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Sinopharm Group Xinjiang Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio
  30. 8.5.5 Sinopharm Group Xinjiang Pharmaceutical Recent Developments
  31. 8.6 Guangdong Xinfeng Pharmaceutical
  32. 8.6.1 Guangdong Xinfeng Pharmaceutical Company Information
  33. 8.6.2 Guangdong Xinfeng Pharmaceutical Business Overview
  34. 8.6.3 Guangdong Xinfeng Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Guangdong Xinfeng Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio
  36. 8.6.5 Guangdong Xinfeng Pharmaceutical Recent Developments
  37. 8.7 Anhui Fengyang Keyuan Pharmaceutical
  38. 8.7.1 Anhui Fengyang Keyuan Pharmaceutical Company Information
  39. 8.7.2 Anhui Fengyang Keyuan Pharmaceutical Business Overview
  40. 8.7.3 Anhui Fengyang Keyuan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Anhui Fengyang Keyuan Pharmaceutical Chinese Medicine Injection for Bones and Muscles Product Portfolio
  42. 8.7.5 Anhui Fengyang Keyuan Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chinese Medicine Injection for Bones and Muscles Value Chain Analysis
  2. 9.1.1 Chinese Medicine Injection for Bones and Muscles Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chinese Medicine Injection for Bones and Muscles Sales Mode & Process
  6. 9.2 Chinese Medicine Injection for Bones and Muscles Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chinese Medicine Injection for Bones and Muscles Distributors
  9. 9.2.3 Chinese Medicine Injection for Bones and Muscles Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst